Powered by: Motilal Oswal
2026-08-04 02:18:19 pm | Source: Accord Fintech
Resonance Specialties touches the roof on getting nod to purchase manufacturing facility in Madhya Pradesh
Resonance Specialties touches the roof on getting nod to purchase manufacturing facility in Madhya Pradesh

Resonance Specialties is currently trading at upper limit of Rs. 154.35, up by 7.35 points or 5.00% from its previous closing of Rs. 147.00 on the BSE.

The scrip opened at Rs. 150.85 and has touched a high and low of Rs. 154.35 and Rs. 147.20 respectively. So far 38630 shares were traded on the counter.

The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 154.35 on 04-Aug-2026 and a 52 week low of Rs. 77.00 on 30-Mar-2026.

Last one week high and low of the scrip stood at Rs. 154.35 and Rs. 137.80 respectively. The current market cap of the company is Rs. 178.18 crore.

The promoters holding in the company stood at 54.25%, while Institutions and Non-Institutions held 1.55% and 44.20% respectively.

Resonance Specialties has received approval for purchase of manufacturing facility situated at Plot No. 6, New Industrial AreaII, Mandideep, Dist Raisen, Madhya Pradesh along with leasehold land, buildings, plant & machineries, licenses, permits, along with employees, etc. from Kaygee Laboratories (KLPL) a related party, for a consideration of Rs 29.98 crore on slump sale basis. 

The said transaction is expected to be completed on or before November 30, 2026 or such other date as may be mutually agreed subject to the necessary consents for the transfer of the leasehold rights on the land on which this manufacturing unit is situated. The Board of Directors of the Company at their meeting held on August 4, 2026 has approved the same. 

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here